NYSE:EMNChemicals
Does Eastman’s Cost Cuts And Kingsport Upside Change The Bull Case For EMN?
In its latest quarterly update, Eastman Chemical reported earnings per share above expectations but slightly missed on revenue, highlighted US$60 million of incremental 2025 earnings from its Kingsport methanolysis facility, raised its dividend for the 16th consecutive year, and returned about US$500 million via dividends and buybacks.
The company also lifted its 2026 cost reduction target to US$125 million–US$150 million and withheld full-year EPS guidance, underscoring both internal...